DJIA 18,064.85 -167.17 -0.92%
NASDAQ 5,037.39 -51.98 -1.02%
S&P 500 2,105.72 -20.34 -0.96%
market minute promo

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

FRX $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS $3.78

Sector

Healthcare

Industry

Drug Makers

Forest Laboratories, Inc. (FRX) Description

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Website: http://www.frx.com/

News & Commentary Rss Feed

Can This Pharma Go From Good to Great?

Will Actavis' $66 billion merger with Allergan catapult this company from good to great? Or could a hidden risk derail this global powerhouse?

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Bill Nygren's Fourth Quarter Commentary - Oakmark Fund

Actavis shares outpace buyout target’s gains

Pfizer held takeover talks with Actavis

Today In SA PRO: Wednesday, September 10

Today In SA PRO: Tuesday, September 9

Today In SA PRO: Monday, September 8

This Week's Outstanding Performance Winners - Jason Radin (Short Fairway) And Buddy Lyons (Long Fore

This Week's Outstanding Performance Winners - Jason Radin (Short Fairway) And Buddy Lyons (Long Forest Labs)

See More FRX News...

FRX's Top Competitors

FRX $0.00 (0.00%)
Current stock: FRX
JNJ $101.10 (-0.25%)
Current stock: JNJ
NVS $102.35 (-1.44%)
Current stock: NVS
RHHBY $36.35 (-1.30%)
Current stock: RHHBY